BRIDGEBIO PHARMA

bridgebio-pharma-logo

BridgeBio is a biotechnology company that focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D. BridgeBio creates a bridge from advancements in genetic science to patients with unmet needs via the entrepreneurial engine required to make life-changing medicines as rapidly as possible. BridgeBio's mission is to discover, create, test, and deliver transformative medicines to treat patients with genetic diseases.

#People #Financial #Website #More

BRIDGEBIO PHARMA

Social Links:

Industry:
Biotechnology Health Care Life Science Medical Pharmaceutical

Founded:
2014-01-01

Address:
Palo Alto, California, United States

Country:
United States

Website Url:
http://www.bridgebio.com

Total Employee:
251+

Status:
Active

Contact:
650-391-9740

Email Addresses:
[email protected]

Total Funding:
1.95 B USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager WordPress Domain Not Resolving Apache



Current Advisors List

randy-scott_image

Randy Scott Director Board Of Directors @ BridgeBio Pharma
Board_member
2020-06-01

laura-a-brege_image

Laura A. Brege Senior Advisor @ BridgeBio Pharma
Advisor
2017-04-01

Current Employees Featured

neil-kumar_image

Neil Kumar
Neil Kumar Co-Founder & CEO @ BridgeBio Pharma
Co-Founder & CEO
2014-09-01

justin-to_image

Justin To
Justin To VP of Business Development and Operations, Gene Therapy @ BridgeBio Pharma
VP of Business Development and Operations, Gene Therapy
2018-03-01

michael-pettigrew_image

Michael Pettigrew
Michael Pettigrew VP, Asset Acquisition @ BridgeBio Pharma
VP, Asset Acquisition
2016-08-01

not_available_image

Uma Sinha
Uma Sinha Chief Scientific Officer @ BridgeBio Pharma
Chief Scientific Officer
2016-04-01

eli-m-wallace_image

Eli M. Wallace
Eli M. Wallace Chief Scientific Officer In Residence @ BridgeBio Pharma
Chief Scientific Officer In Residence
2019-12-01

christine-siu_image

Christine Siu
Christine Siu Chief Operating Officer @ BridgeBio Pharma
Chief Operating Officer
2020-01-01

josh-loehrer_image

Josh Loehrer
Josh Loehrer SVP, People @ BridgeBio Pharma
SVP, People
2021-02-01

frank-mccormick_image

Frank McCormick
Frank McCormick Co-founder @ BridgeBio Pharma
Co-founder
2015-12-01

ali-panjwani_image

Ali Panjwani
Ali Panjwani Director, Pricing & Contracting, Market Access @ BridgeBio Pharma
Director, Pricing & Contracting, Market Access

caroline-landau_image

Caroline Landau
Caroline Landau Director and Gene Therapy Product Planning @ BridgeBio Pharma
Director and Gene Therapy Product Planning
2021-10-01

Founder


frank-mccormick_image

Frank McCormick

neil-kumar_image

Neil Kumar

Stock Details


Company's stock symbol is NASDAQ:BBIO

Acquisitions List

Date Company Article Price
2020-10-05 Eidos Therapeutics Eidos Therapeutics acquired by BridgeBio Pharma 175 M USD

Investors List

perceptive-advisors_image

Perceptive Advisors

Perceptive Advisors investment in Series D - BridgeBio Pharma

sequoia-capital_image

Sequoia Capital

Sequoia Capital investment in Series D - BridgeBio Pharma

aig-investments_image

AIG Investments

AIG Investments investment in Series D - BridgeBio Pharma

cormorant-capital_image

Cormorant Capital

Cormorant Capital investment in Series D - BridgeBio Pharma

aisling-capital_image

Aisling Capital

Aisling Capital investment in Series D - BridgeBio Pharma

viking-global-investors_image

Viking Global Investors

Viking Global Investors investment in Series D - BridgeBio Pharma

herculescapital_image

Hercules Capital

Hercules Capital investment in Series D - BridgeBio Pharma

kkr_image

Kohlberg Kravis Roberts

Kohlberg Kravis Roberts investment in Series D - BridgeBio Pharma

janus-fund_image

Janus Fund

Janus Fund investment in Series C - BridgeBio Pharma

perceptive-advisors_image

Perceptive Advisors

Perceptive Advisors investment in Series C - BridgeBio Pharma

Investments List

Date Company Article Money raised
2018-04-05 Eidos Therapeutics BridgeBio Pharma investment in Series B - Eidos Therapeutics 64 M USD
2018-01-30 QED Therapeutics BridgeBio Pharma investment in Venture Round - QED Therapeutics 65 M USD
2017-08-01 PellePharm BridgeBio Pharma investment in Series B - PellePharm 20 M USD
2015-04-30 MyoKardia BridgeBio Pharma investment in Series B - MyoKardia 46 M USD
2014-08-22 MyoKardia BridgeBio Pharma investment in Venture Round - MyoKardia 10 M USD

Official Site Inspections

http://www.bridgebio.com Semrush global rank: 2.1 M Semrush visits lastest month: 9.77 K

  • Host name: 141.193.213.20
  • IP address: 141.193.213.20
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "BridgeBio Pharma" on Search Engine